NCT05606601

Brief Summary

The purpose of this study is to assess the effectiveness of mobile app containing a range of evidence based tools to improve the mental health and substance use outcomes of university students.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,489

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2022

Completed
26 days until next milestone

Study Start

First participant enrolled

September 28, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 4, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2023

Completed
Last Updated

September 18, 2023

Status Verified

September 1, 2023

Enrollment Period

10 months

First QC Date

September 2, 2022

Last Update Submit

September 14, 2023

Conditions

Keywords

Student Mental HealthAnxietyDepressionAlcohol UseSubstance UseCannabis UseOpioid UseStimulant UseOnline InterventionE-mental Health

Outcome Measures

Primary Outcomes (3)

  • Change in General anxiety symptomology from Baseline to Follow-up at 30 days

    Assessed by the General Anxiety Disorder 7-Item (GAD-7) scale. Changes in anxiety symptomology from baseline to follow-up at 30 days will be based on total scores on the GAD-7 in both the intervention and control groups. Total scores range from 0 to 21 with higher scores indicating a worse outcome (i.e, a greater frequency of anxiety symptoms).

    The GAD-7 will be administered to both the intervention and control groups at baseline and 30 days.

  • Change in Depressive symptomology from Baseline to Follow-up at 30 days

    Assessed by the Patient Health Questionnaire 9-item (PHQ-9) scale. Changes in depressive symptomology from baseline to follow-up at 30 days will be based on total scores on the PHQ-9 in both the intervention and control groups. Total scores range from 0 to 29 with higher scores indicating a worse outcome (i.e., a greater frequency of depression symptoms).

    The PHQ-9 will be administered to both the intervention and control group at baseline and 30 days.

  • Change in Alcohol consumption risk from Baseline to Follow-up at 30 days

    Assessed by the alcohol consumption questions of the Alcohol Use Disorders Identification Test, Adapted for Use in the United States (USAUDIT-C). Changes in alcohol consumption risk from baseline to follow-up at 30 days will be based on total scores on the USAUDIT-C in both the intervention and control groups. Total scores range from 0 to 18 with higher scores indicating a worse outcome (i.e., a higher level of risky drinking).

    The USAUDIT-C will be administered to the intervention and control groups at baseline and 30 days.

Secondary Outcomes (10)

  • Frequency of cannabis consumption

    Frequency of cannabis consumption will be assessed in the intervention and control groups at baseline and at 30 days.

  • Frequency of binge drinking

    Frequency of binge drinking will be assessed in the intervention and control groups at baseline and at 30 days.

  • Frequency of alcohol use

    Frequency of alcohol use will be assessed in the intervention and control groups at baseline and at 30 days.

  • Frequency of opioid use

    Frequency of opioid use will be assessed in the intervention and control groups at baseline and at 30 days.

  • Frequency of non-medical stimulant use

    Frequency of non-medical stimulant use will be assessed in the intervention and control groups at baseline and at 30 days.

  • +5 more secondary outcomes

Study Arms (2)

Intervention arm

EXPERIMENTAL

Participants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.

Behavioral: Minder

Control arm

NO INTERVENTION

Participants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.

Interventions

MinderBEHAVIORAL

There are four main components of the Minder app: The Chatbot, Services, Community, and Peer Coaching components. The Services component asks participants to complete a series of questions on various mental health, substance use, and general life issues. It then recommends community and on-campus resources based on their current needs. The Community component of the app matches individuals with groups (e.g., student clubs) and events at the university or in the broader community that they may be interested in. The Chatbot component of the app contains pre-formatted conversational scripts that users engage with via a "chatbot" and videos designed to teach evidence-based skills (e.g., cognitive strategies to manage anxiety) that can be applied to everyday life. To support use of the app, all users in the intervention group will be offered access to trained peer coaches to help users navigate the different app components and provide non-clinical peer support.

Intervention arm

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Must be currently enrolled at participating university
  • Must be 17 years or older
  • Must have access to and be able to use a smart phone with Wi-Fi and/or mobile data
  • Must be English speaking

You may not qualify if:

  • \) Any participants that self-identify as currently having a suicidal plan at the time of study enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia

Vancouver, British Columbia, V6T 2A1, Canada

Location

Related Publications (3)

  • Y Wang A, Vereschagin M, G Richardson C, J Munthali R, Xie H, L Hudec K, Mori T, Munro L, V Vigo D. Examining the effects of engagement with an app-based mental health intervention: a secondary analysis of a randomized control trial with treatment non-compliance. Int J Ment Health Syst. 2025 Oct 9;19(1):30. doi: 10.1186/s13033-025-00688-4.

  • Vereschagin M, Wang AY, Richardson CG, Xie H, Munthali RJ, Hudec KL, Leung C, Wojcik KD, Munro L, Halli P, Kessler RC, Vigo DV. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial. J Med Internet Res. 2024 Mar 27;26:e54287. doi: 10.2196/54287.

  • Wang AY, Vereschagin M, Richardson CG, Xie H, Hudec KL, Munthali RJ, Munro L, Leung C, Kessler RC, Vigo DV. Evaluating the Effectiveness of a Codeveloped e-Mental Health Intervention for University Students: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Aug 30;12:e49364. doi: 10.2196/49364.

MeSH Terms

Conditions

Anxiety DisordersDepressionAlcohol DrinkingSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorDrinking BehaviorChemically-Induced Disorders

Study Officials

  • Daniel V Vigo, MD, Lic. Psych, DrPH

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Single blinded in that only the investigators (including the statistician) will be blinded to the treatment group assignment when examining the primary hypotheses.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 2, 2022

First Posted

November 4, 2022

Study Start

September 28, 2022

Primary Completion

July 21, 2023

Study Completion

July 21, 2023

Last Updated

September 18, 2023

Record last verified: 2023-09

Locations